Cell Signaling Technology

  • Research Associate - Flow Cytometry

    Job Locations US-MA-Danvers
    Posted Date 1 month ago(10/16/2018 2:03 PM)
    Job ID
    2018-1142
    Category
    Product Development
  • Company Overview

    Cell Signaling Technology, Inc. (CST) is a worldwide leader in the development and commercialization of antibodies, assays and research tools. As a company of scientists for scientists, we have developed PTMScan®, a technology to discover protein post-translational modifications, P hosphoSitePlus®, an online resource for investigation of post-translational modifications, and XMT® technology, a proprietary method to develop exceptional monoclonal antibodies. We are fully committed to developing new research tools to help define the mechanisms underlying cell function and disease, thereby broadly accelerating progress in biomedical research and medicine.

    Position Summary

    Our Flow Cytometry group is seeking a Research Associate who will be actively engaged in thorough scientific validation of antibodies and antibody conjugates, using a wide array of flow cytometry assays and techniques. The mission of the Flow Cytometry Core is to provide a centralized resource for the analysis of reagent performance along various stages of research, development, and production. This includes assessment of antibody utility for flow cytometry assays of cell lines, whole blood, and dissociated tissue. As experts in flow cytometry, team members will function as collaborative partners in the design, execution, and troubleshooting of experiments with internal and external customers.

    Responsibilities

    • Design and execute experiments to fulfill testing requirements in support of antibody validation
    • Ensure accurate and reproducible testing of materials, adhering to established protocols
    • Collaborate with scientific teams to optimize biological models
    • Effectively multitask to complete experiments efficiently with minimal flaws, and within expected service level agreements
    • Configure and utilize flow cytometers to acquire accurate and interpretable data
    • Utilize analytical software to draw informed conclusions regarding performance of materials tested
    • Produce high quality data visualizations, meeting standard requirements for product marketing materials
    • Effectively communicate experimental results to stakeholders providing clear substantiation through data acquired during testing
    • Maintain accurate and complete documentation of experiments in appropriate systems (e.g. notebooks, electronic systems) in accordance with CST quality systems requirements
    • Continuously seek techniques and technological opportunities that will improve quality, efficiency, or scalability of flow cytometry

    Qualifications

    Required Skills/Experience:

    • Bachelor’s degree in a biological science (e.g. molecular biology, cell biology, biochemistry or biotechnology); Cell Biology or Biochemistry preferred
    • Minimum 2 years of relevant laboratory experience in academic, pharmaceutical or biotechnology setting
    • Demonstrated knowledge and understanding of biological processes
    • Computer proficiency, including working knowledge of MS Office and Google suites (or related) applications

    Preferred Skills/Experience:

    • 1 year previous experience performing and analyzing flow cytometry assays
    • Familiarity with various flow cytometry data analysis platforms
    • Ability to analyze and solve basic scientific problems
    • Strong written and oral communication skills
    • Highly motivated and comfortable at multitasking

    Cell Signaling Technology, Inc. is committed to providing equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, status as a veteran or as a member of the military or status in any group protected by applicable federal or state laws.

    Options

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed